A Comparative Study of the Respiratory Neonatal Outcomes Utilizing Dexamethasone Sodium Phosphate versus a Mixture of Betamethasone Dipropionate and Betamethasone Sodium Phosphate as an Antenatal Corticosteroid Therapy

References

• Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37–e46. doi:10.1016/S2214-109X(18)30451-0
   PubMed Web of Science ®Google Scholar
• Dbstet A. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977;56(3):247–253.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi:10.1016/S0140-6736(08)60074-4
   PubMed Web of Science ®Google Scholar
• You D, New J, Wardlaw T. Levels and Trends in Child Mortality. Report 2015. Estimates Developed by the UN Inter-Agency Group for Child Mortality Estimation. New York: United Nations Children’s Fund; 2015:2017.
   Google Scholar
• Platt MJ. Outcomes in preterm infants. Public Health. 2014;128(5):399–403. doi:10.1016/j.puhe.2014.03.010
   PubMed Web of Science ®Google Scholar
• Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy. Early Hum Dev. 2010;86(6):329–338. doi:10.1016/j.earlhumdev.2010.05.010
   PubMed Web of Science ®Google Scholar
• Torloni MR, Betrán AP, Daher S, et al. Maternal BMI and preterm birth: a systematic review of the literature with meta-analysis. J Matern Fetal Neonatal Med. 2009;22(11):957–970. doi:10.3109/14767050903042561
   PubMed Web of Science ®Google Scholar
• Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368(9543):1271–1283. doi:10.1016/S0140-6736(06)69525-1
   PubMed Web of Science ®Google Scholar
• Pisoni C, Spairani S, Manzoni F, et al. Depressive symptoms and maternal psychological distress during early infancy: a pilot study in preterm as compared with term mother-infant dyads. J Affect Disord. 2019;257:470–476. doi:10.1016/j.jad.2019.07.039
   PubMed Web of Science ®Google Scholar
• Bérard A, Le Tiec M, De Vera MA. Study of the costs and morbidities of late-preterm birth. Arch Dis Child Fetal Neonatal Ed. 2012;97(5):F329–F334. doi:10.1136/fetalneonatal-2011-300969
   PubMed Web of Science ®Google Scholar
• Travers CP, Clark RH, Spitzer AR, Das A, Garite TJ, Carlo WA. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ. 2017;356:j1039–j1039. doi:10.1136/bmj.j1039
   PubMed Web of Science ®Google Scholar
• Delara M, Chauhan BF, Le ML, Abou-Setta AM, Zarychanski R, TJong GW. Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2019;104(2):F137–f144. doi:10.1136/archdischild-2017-314046
   PubMed Web of Science ®Google Scholar
• Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 1995;173(1):254–262. doi:10.1016/0002-9378(95)90210-4
   PubMed Web of Science ®Google Scholar
• Hallman M, Peltoniemi O, Kari MA. Enhancing functional maturity before preterm birth. Neonatology. 2010;97(4):373–378. doi:10.1159/000297768
   PubMed Web of Science ®Google Scholar
• Tsakiridis I, Mamopoulos A, Athanasiadis A, Dagklis T. Antenatal corticosteroids and magnesium sulfate for improved preterm neonatal outcomes: a review of guidelines. Obstet Gynecol Surv. 2020;75(5):298–307. doi:10.1097/ogx.0000000000000778
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172. doi:10.1016/s0140-6736(12)60820-4
   PubMed Web of Science ®Google Scholar
• Alshari O, Al Zu’bi YO, Al Sharie AH, et al. Evaluating the prognostic role of monocytopenia in chemotherapy-induced febrile neutropenia patients treated with granulocyte colony-stimulating factor. Ther Clin Risk Manag. 2021;17:963–973. doi:10.2147/TCRM.S318370
   PubMed Web of Science ®Google Scholar
• Guéguen N, Lourel M, Pascual A, Mouda F. A simple method to determine and evaluate “effect size”. Sante. 2011;21(2):103–105. L’importance d’un effet: méthodologie simple de détermination et d’évaluation de l’« effect size ». doi:10.1684/san.2011.0240
   PubMedGoogle Scholar
• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515.
   PubMed Web of Science ®Google Scholar
• Lee SK, Qi Z. Antenatal corticosteroids prior to preterm birth: betamethasone or dexamethasone? Lancet Child Adolesc Health. 2019;3(11):750–751. doi:10.1016/S2352-4642(19)30293-7
   PubMedGoogle Scholar
• Crowther CA, Ashwood P, Andersen CC, et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019;3(11):769–780. doi:10.1016/S2352-4642(19)30292-5
   PubMedGoogle Scholar
• Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454–CD004454. doi:10.1002/14651858.CD004454.pub3
   PubMed Web of Science ®Google Scholar
• Kopylov AT, Novikov AA, Kaysheva AL, et al. Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study. J Pharm Biomed Anal. 2018;149:278–289. doi:10.1016/j.jpba.2017.11.021
   PubMed Web of Science ®Google Scholar
• Salem II, Najib NM. Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. Clin Ther. 2012;34(1):214–220. doi:10.1016/j.clinthera.2011.11.022
   PubMed Web of Science ®Google Scholar
• Jobe AH, Kemp M, Schmidt A, Takahashi T, Newnham J, Milad M. Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatr Res. 2020;2020. doi:10.1038/s41390-020-01249-w
   Web of Science ®Google Scholar
• Altal OF, Aleshawi AJ, Khrais MZ, et al. The practice of intracytoplasmic sperm injection in Jordan: a clinical outcome study. Ann Med Surg. 2020;57:196–200. doi:10.1016/j.amsu.2020.07.042
   PubMed Web of Science ®Google Scholar
• Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birth weight and head circumference? Obstet Gynecol. 2002;99(1):101–108. doi:10.1016/S0029-7844(01)01656-8
   PubMed Web of Science ®Google Scholar
• Bloom SL, Sheffield JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol. 2001;97(4):485–490. doi:10.1016/S0029-7844(00)01206-0
   PubMed Web of Science ®Google Scholar
• Murphy KE, Willan AR, Hannah ME, et al. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol. 2012;119(5):917–923. doi:10.1097/AOG.0b013e31825189dc
   PubMed Web of Science ®Google Scholar
• Norberg H, Stålnacke J, Heijtz RD, et al. Antenatal corticosteroids for preterm birth: dose-dependent reduction in birthweight, length and head circumference. Acta Paediatr. 2011;100(3):364–369. doi:10.1111/j.1651-2227.2010.02074.x
   PubMed Web of Science ®Google Scholar
• French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 1999;180(1):114–121. doi:10.1016/S0002-9378(99)70160-2
   PubMed Web of Science ®Google Scholar
• Ciapponi A, Klein K, Colaci D, et al. Dexamethasone vs. betamethasone for preterm birth: a systematic review and network meta-analysis. Authorea. 2020. doi:10.22541/au.159248834.46935661
   Google Scholar
• Jobe AH, Milad MA, Peppard T, Jusko WJ. Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India. Clin Transl Sci. 2020;13(2):391–399. doi:10.1111/cts.12724
   PubMed Web of Science ®Google Scholar
• Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH. Antenatal corticosteroids beyond 34 weeks gestation: what do we do now? Am J Obstet Gynecol. 2016;215(4):423–430. doi:10.1016/j.ajog.2016.06.023
   PubMed Web of Science ®Google Scholar
• Porto AMF, Coutinho IC, Correia JB, Amorim MMR. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ. 2011;342:d1696. doi:10.1136/bmj.d1696
   PubMed Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Gilbert S, Landon MB, et al. Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth. Obstet Gynecol. 2012;119(3):555–559. doi:10.1097/AOG.0b013e31824758f6
   PubMed Web of Science ®Google Scholar
• Kirshenbaum M, Mazaki-Tovi S, Amikam U, et al. Does antenatal steroids treatment prior to elective cesarean section at 34–37 weeks of gestation reduce neonatal morbidity? Evidence from a case control study. Arch Gynecol Obstet. 2018;297(1):101–107. doi:10.1007/s00404-017-4557-8
   PubMed Web of Science ®Google Scholar
• Üstün N, Hocaoğlu M, Turgut A, Arslanoğlu S, Ovalı F. Does antenatal corticosteroid therapy improve neonatal outcomes in late preterm birth? J Matern Fetal Neonatal Med. 2020:1–7. doi:10.1080/14767058.2020.1808614
   PubMed Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320. doi:10.1056/NEJMoa1516783
   PubMed Web of Science ®Google Scholar
• Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG. 2003;110(s20):8–16. doi:10.1046/j.1471-0528.2003.00012.x
   PubMed Web of Science ®Google Scholar
• Travers CP, Carlo WA, McDonald SA, et al. Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids. Am J Obstet Gynecol. 2018;218(1):130.e1–130.e13. doi:10.1016/j.ajog.2017.11.554
   PubMed Web of Science ®Google Scholar
• Gázquez Serrano IM, Arroyos Plana A, Díaz Morales O, Herráiz Perea C, Holgueras Bragado A. Antenatal corticosteroid therapy and late preterm infant morbidity and mortality. An Pediatr. 2014;81(6):374–382. doi:10.1016/j.anpede.2014.01.003
   Google Scholar
• Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA. 2020;323(19):1924–1933. doi:10.1001/jama.2020.3937
   PubMed Web of Science ®Google Scholar